The mechanism of action of a novel compound, 2,5-di-(t-butyl)-1,4-benzohydroquinone (BHQ), used to modulate cell free cytosolic Ca2+ concentration ([Ca2+] levels in resting or stimulated cells. Therefore, the effect of"BHQ appears to involve unmasking of passive Ca2+-permeation pathways in the plasma and intracellular membranes that do not respond to cholecystokinin octapeptide,'following its described inhibition of the internal-store Ca2+ pumps responsible for accumulating Ca2+ in these pools.
INTRODUCTION
Mobilization of Ca2+ across the plasma and intracellular membranes is a major pathway of stimulus-response coupling in many cell types [1] [2] [3] [4] . Ca2+ release from intracellular stores is responsible for the initial rapid increase in [Ca2l] ,, which is thought to be mediated by the generation of Ins (1, 4, 5) P3 in the cytosol [5] . Mobilization of extracellular Ca2' due to activation of receptor-operated Ca2+ entry pathways is responsible for steady-state elevation of [Ca2+] i [3, 4] . This pathway is also responsible for reloading of the intracellular pools [4] and maintaining [Ca2+] , oscillation [5, 6] . These pathways, which increase [Ca2+]1 in response to cell activation, are counteracted by primary active Ca2+ pumps located in both intracellular and plasma membranes. Monoclonal antibodies [7] and cloning techniques [8] have identified several isoforms of the intracellular Ca2+ pumps which are thought to be located in separate Ca2+ stores [6, 7] . Activation of these various pathways, which differ in relative importance in different cell types and in terms of responses to different agonists [4, 9, 10] , results in a characteristic biphasic change in [Ca2+] , observed in non-excitable cells [4] and can also lead to oscillatory rather than steady-state changes in [Ca2+]i, [5, 6] .
Studies designed to elucidate the relative importance of the various Ca2+-regulatory systems have been hampered by the lack of specific inhibitors of Ca2+ pumps or passive Ca2+ pathways. However, a tool which has become popular recently in studying Ca2+ homoeostasis in cells is the inhibition of the intracellular Ca2+ pump by compounds such as the sesquiterpene lactone thapsigargin [11] and the benzohydroquinone BHQ [12] . Both of these compounds were found to be potent inhibitors of intracellular Ca2+ pumps [13, 14] without affecting the Ca2+ pumps located in the plasma membrane or passive Ca2+ pathways [13, 14] . Hence changes in [Ca2+]1 brought about by the addition of these agents have been ascribed to inhibition of the Ca 2+_ scavenging action of the intracellular pumps [1 1,12,15,16] . From studying the effects of these compounds on agonist-evoked [Ca2+]1 increase, it was further suggested that these compounds mobilize the agonist-sensitive pool to increase [Ca2+] i [12, [15] [16] [17] .
In the present work, we have used the pancreatic tumour cell line AR42J and freshly isolated pancreatic acini to determine the sites of interaction of BHQ with Ca2+-regulatory mechanisms. We provide evidence that treatment with BHQ results in mobilization of Ca2+ from two separate intracellular pools, an agonist-sensitive and an agonist-insensitive pool. Ca2+ mobilization from the agonist-insensitive pool is rapid and accounts for the initial BHQ-evoked [Ca2+]i increase, whereas Ca2+ mobilization from the agonist-sensitive pool is slow and results in time-dependent inhibition of agonist-evoked [Ca2+]i increase. BHQ appears to increase [Ca2+] , rapidly by unmasking the activity of a Ca2+ channel after the inhibition of internal Ca2+ pumps. 
METHODS

Preparation of acini
Dispersed pancreatic acini were prepared from rat pancreas by two cycles ofcollagenase digestion as described previously [18, 19] . The acini from one pancreas were suspended in 10 ml of serumfree tissue-culture medium containing 1 mg of BSA/ml and 0.01I% (w/v) soybean trypsin inhibitor (incubation solution) and kept on ice until use. A 2 ml portion of acini suspension was used for each loading with Fura 2. The acini were placed in incubation solution containing 5 ,um-Fura 2/AM for 30 min at 37 'C. After completion of Fura 2 loading, the acini were washed once and resuspended in a final volume of 10 ml of incubation solution. The Fura 2-loaded acini were placed on ice until attachment to cover-slips. The acini were then plated on thin glass cover-slips coated with a thin film of polylysine and allowed to attach for 20-30 min at room temperature before the cover-slip was mounted in the perfusion chamber. The acini were perfused with solution A [140 mM-NaCl, 5 mm-KCl, 1 mM-MgCl2, 10 mMHepes (pH 7.4 with NaOH), 10 mM-glucose and 0.1 % BSA) at 37 "C for at least 10 min before a challenge with agonist or BHQ.
Fluorescence recording from single cells
The cover-slips with AR42J cells or pancreatic acini attached to them were mounted in an open perfusion chamber. The perfusate volume in the chamber was adjusted to 0.3 ml. The perfusate, placed in 60 ml syringes, was delivered through an eight-way valve to spiral-shaped glass tubing that was waterjacketed and kept at 37 "C. From the glass tubing, a warm perfusate was delivered to the chamber, which was also heated by means of a circulating water bath that allowed water flow through metal tubing which fitted in the bottom of the chamber. The cells were continuously perfused at a flow rate of [10] [11] [12] RP-C18. The purified peptides were subjected to automatic gasphase sequencing. Peptides T 3/4 (7-18) and T BHQ-sensitive Ca2+ pools In this set of experiments, the location of the releasable Ca2+ was investigated. Fig. 4(a) This could perhaps be accounted for by an activation of the plasma-membrane Ca2+ pump by agonists [25, 26] . Hence there is a rapidly mobilized pool of intracellular Ca2+ sensitive to BHQ but insensitive to Ins(1,4,5)P3-mediated agonists.
To characterize further the relationship between BHQ and agonist mobilization of Ca2 , we determined the time course of inhibition of the agonist response by BHQ (Fig. 5) . Stimulation with CCK-OP of a cell incubated with BHQ for 1 min increased fCa2+]i to 775 nM (Fig. 5a) respectively. Incubation with BHQ for 7.5 min (Fig. 5e) [27] , similar to those observed in pancreatic acinar cells [28] . Fig. 6(a) (Fig. 5) .
Effects of manoalide
Mobilization of intracellular Ca2' by BHQ was attributed to its ability to inhibit the internal Ca2+ pump [12, 26] . However, the results in Fig. 7 shown that manoalide is a potent inhibitor of Ca2+ channels, including Ca2+ release from intracellular stores [29] . Fig. 8 [27] and both can be blocked by manoalide [29] .
In the next set of experiments we tested the ability of manoalide to inhibit the BHQ-evoked [Ca2+]i increase. Fig. 9 the inhibition of Ca2+ uptake by BHQ. The experiments in Figs. 10 and 11 further support our previous findings [29] showing that the effects of manoalide on [Ca2+]i are due to inhibition of passive Ca2+ pathways. Previous studies showed that BHQ [12] and manoalide [29] at the concentrations used had no effect on total production of InsP3. To exclude the possibility that the drugs specifically inhibit production of the 1,4,5 isomer of InsPJ, we performed mass measurements of Ins(1,4,5)P3 in resting and stimulated cells. Table 1 shows that in AR42J cells 5-10 s of stimulation with CCK-OP increased Ins(1,4,5)P3 by approx. 12-fold. Incubation with 25 ,sM-BHQ for 5-300 s or with 1.5 ,uM-manoalide for 300 s had no measurable effect on Ins(1,4,5)P3 levels. Similar incubation had no effect on the ability of CCK-OP to increase Ins (1,4,5 [20] , so that Mn2' entry can be monitored without interference from the change in [Ca2+]i [30, 31] [12, 33] .
These observations were interpreted to suggest that BHQ mobilizes Ca2+ from intracellular stores without a change in plasma-membrane permeability to Ca2+ [12, 26, 33] . The transient (Figs. 1 and 3) as compared with the sustained [12, 26] nature of the response in the two studies might be explained by the recording system used. It is more difficult to account for the results with Mn2 . We have no immediate explanation for these differences although it is possible that the Ca2+-entry pathways activated by BHQ in hepatocytes do not transport Mn2+ in a manner similar to that in AR42J cells and pancreatic acini.
The effects of BHQ on [Ca2+]i in AR42J cells resemble the effects described for thapsigargin in several cell types.
Thapsigargin mobilized Ca2+ from intracellular stores [11, 15, 16] , caused sustained increase in [Ca2+]i [15, 17] and increased Mn2+ influx [34] . Mobilization of intracellular Ca2+ by BHQ and thapsigargin did not involve a change in Ins(l,4,5)P3 ( [12, 17] , and the present work). However, the separation of intracellular Ca2+ into two distinct pools has not been described previously by using this class of reagents. Our results cannot be interpreted as direct activation of Ca2+ entry by BHQ. It is possible that Ca2+ release from intracellular pools was sufficient to trigger Ca2+ entry. It was shown in several cell types that mobilization of intracellular Ca2+ through receptor-mediated [32, [35] [36] [37] or receptor-independent [17, 34] means was sufficient to activate Ca2+ entry, which persisted also after removal of the agonist [32, [35] [36] [37] . If this mechanism accounts for the activation of Ca2+ entry by BHQ, then our results suggest that Ca2+ release from either the agonist-sensitive or the agonist-insensitive pools can activate Ca2+ entry in AR42J cells and pancreatic acini.
Our results suggest that BHQ treatment leads to Ca2+ release from two separate pools, an agonist-sensitive and an agonistinsensitive pool. Ca2' release from the agonist-insensitive pool is rapid and responsible for the initial BHQ-mediated [Ca2+]i increase, whereas depletion of the agonist-sensitive pool by BHQ is slow. This is concluded from the following: (a) exposure of cells to BHQ and agonist increased [Ca2+]i to levels higher than those observed with either BHQ or the agonist (Fig. 4b); (b) BHQ can still increase [Ca2+]i in cells whose agonistmobilizable pool has been depleted (Fig. 4a) [12, 14] and that it had no effect on passive Ca2+ fluxes in these membranes [14] . Hence (Fig. 7) . However, the most compelling evidence for the involvement of Ca2+ channels in the initial BHQ-mediated Ca2+ release was obtained with the use of manoalide. Manoalide is a potent inhibitor of various types of Ca2+ channels, including agonist-mediated Ca2+ release from internal stores and Ca2+ entry [29] . We 
